Articles:

Future proofing is a consideration, because when new materials and improvements in the industry arise, we want to be able to make best use of them without having to substantially change designs.

, or attend online:.https://bit.ly/PDJLecture.

Meeting ID: 876 1663 6350.Passcode: 932368.Professor John Dyson spent more than 25 years at GlaxoSmithKline, eventually ending his career as VP, Head of Capital Strategy and Design, where he focussed on developing a long-term strategic approach to asset management..

While there, he engaged Bryden Wood and together they developed the Front End Factory, a collaborative endeavour to explore how to turn purpose and strategy into the right projects – which paved the way for Design to Value.He is committed to the betterment of lives through individual and collective endeavours.. As well as his business and pharmaceutical experience, Dyson is Professor of Human Enterprise at the University of Birmingham, focussing on project management, business strategy and collaboration.. Additionally, he is a qualified counsellor with a private practice and looks to bring the understanding of human behaviour into business and projects.. To learn more about our Design to Value philosophy, read Design to Value: The architecture of holistic design and creative technology by Professor John Dyson, Mark Bryden, Jaimie Johnston MBE and Martin Wood.

Available to purchase at.Like many, I am torn.

I am very clear that we are at a Rubicon for human life, we are rapidly changing the environment and damaging the eco-system.a portfolio of new pharmaceutical products.

I started with the basis that each new product would follow one of four trajectories of sales.The first would be that it hit a base demand.

, the second 1.5 x base demand, the third 0.5 x base demand and the fourth did not get launched or sold at all or 0.The demand curves were normalised curves.. To simply represent a portfolio of products I allocated a probability to each of the four trajectories.. Then I looked at scale.